Compare ATLO & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATLO | NNNN |
|---|---|---|
| Founded | 1903 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.3M | 340.2M |
| IPO Year | 2001 | 2023 |
| Metric | ATLO | NNNN |
|---|---|---|
| Price | $32.33 | $6.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.3K | ★ 222.7K |
| Earning Date | 04-24-2026 | 04-07-2026 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $83.74 | $446.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.56 | $6.13 |
| 52 Week High | $32.53 | $51.33 |
| Indicator | ATLO | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 29.63 |
| Support Level | $28.55 | N/A |
| Resistance Level | N/A | $13.46 |
| Average True Range (ATR) | 0.72 | 0.72 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 84.24 | 13.33 |
Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).